Bruno Varet

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

François‐Xavier Mahon, Delphine Réa, Joëlle Guilhot et al. · The Lancet Oncology · 2010 · 1.5K citations

Hematological Malignancy, Oncology, Chronic Myeloid Leukaemia +8

Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

Nicole Casadevall, J Nataf, B Viron et al. · New England Journal of Medicine · 2002 · 1.2K citations

Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection

Olivier Hermine, François Lefrère, Jean–Pierre Bronowicki et al. · New England Journal of Medicine · 2002 · 798 citations · Full text

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia

Gabriel Étienne, Joëlle Guilhot, Delphine Réa et al. · Journal of Clinical Oncology · 2016 · 484 citations

Hematological Malignancy, Stop Imatinib, Chronic Myeloid Leukemia +14

Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney.

C. Lacombe, J L Da Silva, Patrick Bruneval et al. · Journal of Clinical Investigation · 1988 · 445 citations · Full text

Histocompatibility, Immunology, Renal Inflammation +19